Login / Signup

Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.

Byron L LamMark E PennesiChristine N KaySushil PandaJames A GowGuolin ZhaoRobert E MacLarennull null
Published in: Ophthalmology (2024)
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Keyphrases
  • open label
  • double blind
  • placebo controlled
  • phase iii
  • phase ii
  • clinical trial
  • study protocol